These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 27586674
1. The Role of Notch1 Signaling in Anaplastic Thyroid Carcinoma. Kim HJ, Kim MJ, Kim A, Jung CW, Park S, Koh JS, Myung JK. Cancer Res Treat; 2017 Apr; 49(2):509-517. PubMed ID: 27586674 [Abstract] [Full Text] [Related]
2. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo. Zhang K, Yu M, Hao F, Dong A, Chen D. Cancer Biomark; 2016 Sep 26; 17(3):281-291. PubMed ID: 27802204 [Abstract] [Full Text] [Related]
3. Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma. Jung CW, Han KH, Seol H, Park S, Koh JS, Lee SS, Kim MJ, Choi IJ, Myung JK. Int J Clin Exp Pathol; 2015 Sep 26; 8(1):560-8. PubMed ID: 25755746 [Abstract] [Full Text] [Related]
5. Suberoyl bis-hydroxamic acid activates Notch1 signaling and induces apoptosis in anaplastic thyroid carcinoma through p53. Li J, Zheng X, Gao M, Zhao J, Li Y, Meng X, Qian B, Li J. Oncol Rep; 2017 Jan 26; 37(1):458-464. PubMed ID: 28004113 [Abstract] [Full Text] [Related]
6. Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer. Patel PN, Yu XM, Jaskula-Sztul R, Chen H. Ann Surg Oncol; 2014 Dec 26; 21 Suppl 4(0 4):S497-504. PubMed ID: 24419754 [Abstract] [Full Text] [Related]
7. FOXD3 regulates anaplastic thyroid cancer progression. Yin H, Meng T, Zhou L, Zhao F, Li X, Li Y, Hu M, Chen H, Song D. Oncotarget; 2017 May 16; 8(20):33644-33651. PubMed ID: 28430585 [Abstract] [Full Text] [Related]
8. Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation. Zhong Z, Hu Z, Jiang Y, Sun R, Chen X, Chu H, Zeng M, Sun C. Oncotarget; 2016 Sep 13; 7(37):59652-59663. PubMed ID: 27487122 [Abstract] [Full Text] [Related]
9. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo. Yu XM, Phan T, Patel PN, Jaskula-Sztul R, Chen H. Cancer; 2013 Feb 15; 119(4):774-81. PubMed ID: 22991264 [Abstract] [Full Text] [Related]
10. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients. Fourati A, El Amine O, Ben Ayoub W, Cherni I, Goucha A, El May MV, Gamoudi A, El May A. Bull Cancer; 2017 May 15; 104(5):433-441. PubMed ID: 28185633 [Abstract] [Full Text] [Related]
11. Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 α/β pathways. Orlandella FM, Mariniello RM, Iervolino PLC, Auletta L, De Stefano AE, Ugolini C, Greco A, Mirabelli P, Pane K, Franzese M, Denaro M, Basolo F, Salvatore G. Mol Carcinog; 2019 Jul 15; 58(7):1181-1193. PubMed ID: 30834573 [Abstract] [Full Text] [Related]
12. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth. Yu XM, Jaskula-Sztul R, Ahmed K, Harrison AD, Kunnimalaiyaan M, Chen H. Mol Cancer Ther; 2013 Jul 15; 12(7):1276-87. PubMed ID: 23594881 [Abstract] [Full Text] [Related]
13. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer. Lee SI, Kim DK, Seo EJ, Choi EJ, Kwon YW, Jang IH, Lee JC, Kim HY, Shong M, Kim JH, Kim SJ. Thyroid; 2017 Nov 15; 27(11):1424-1432. PubMed ID: 28920531 [Abstract] [Full Text] [Related]
14. Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer. Antognelli C, Moretti S, Frosini R, Puxeddu E, Sidoni A, Talesa VN. Cells; 2019 Jun 06; 8(6):. PubMed ID: 31174324 [Abstract] [Full Text] [Related]
15. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells. Han B, Liu SH, Guo WD, Zhang B, Wang JP, Cao YK, Liu J. World J Gastroenterol; 2015 Sep 07; 21(33):9727-35. PubMed ID: 26361419 [Abstract] [Full Text] [Related]
16. Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer. Chen J, Zhao D, Meng Q. Biomed Pharmacother; 2019 Aug 07; 116():108966. PubMed ID: 31102936 [Abstract] [Full Text] [Related]
17. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals. Hao F, Zhu Q, Lu L, Sun S, Huang Y, Zhang J, Liu Z, Miao Y, Jiao X, Chen D. Oncol Res; 2020 Sep 01; 28(4):345-355. PubMed ID: 32138807 [Abstract] [Full Text] [Related]
18. HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1. Pan Z, Fang Q, Li L, Zhang Y, Xu T, Liu Y, Zheng X, Tan Z, Huang P, Ge M. Cancer Lett; 2021 Mar 31; 501():31-42. PubMed ID: 33359451 [Abstract] [Full Text] [Related]
19. Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells. Chin LH, Hsu SP, Zhong WB, Liang YC. Mol Carcinog; 2016 May 31; 55(5):622-32. PubMed ID: 25773758 [Abstract] [Full Text] [Related]
20. Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas. Wang Y, Hardin H, Chu YH, Esbona K, Zhang R, Lloyd RV. Endocr Pathol; 2019 Dec 31; 30(4):262-269. PubMed ID: 31468286 [Abstract] [Full Text] [Related] Page: [Next] [New Search]